Baqsimi

Amphastar Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 15, 2024
Approval ID: f1f5df9b-872f-44e5-a18f-f0b68e7e9254
Products: 0 registered
Version: 4

Regulatory Information

Labeling Type

34391-3

Status

Approved

Full Title

{"br": [null, null], "#text": "These highlights do not include all the information needed to use BAQSIMI safely and effectively. See full prescribing information for BAQSIMI.BAQSIMI (glucagon) nasal powderInitial U.S. Approval: 1960"}

Quick Stats

Total Products0

Labelers1

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.